Peter Wijngaard, Director at Hepion Pharmaceuticals, Inc. (HEPA), bought 3,000 shares at $5.64 ($17K) on 2023-09-19, disclosed to the SEC on 2023-09-20.
Open-market purchase of $17k HEPA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.37 | 861 | $5K | 27.5% |
| 2 | $5.45 | 139 | $758 | 4.5% |
| 3 | $5.82 | 1,000 | $6K | 34.6% |
| 4 | $5.64 | 1,000 | $6K | 33.5% |
| Total | $5.61 avg | 3,000 | $17K | 100% |
| Filing → |
| HEPA | BUY | 2020-12-21 | $38K | — | Filing → |